**Core tip:** Hereditary spastic paraplegias are a group of genetically and clinically heterogeneous neurodegenerative diseases characterized by lower limbs spasticity and weakness. Here we reported a novel *ATL1* Q251R mutation predicted to be pathogenic and a novel clinical phenotype of hearing loss in a Chinese SPG3A family, which expands the clinical and genetic spectrum of *ATL1* mutations.

INTRODUCTION
============

Hereditary spastic paraplegias (HSPs), also called spastic paraplegias (SPGs), are a group of genetically and clinically heterogeneous neurodegenerative diseases characterized by lower limbs spasticity and weakness. HSP can be classified into pure and complicated HSP based on symptoms. In pure HSP, the patient simply develops spasticity and weakness in lower limbs, while in complicated HSP, the patient presents with lower limbs spasticity accompanied by other symptoms, such as seizure and ataxia\[[@B1]\]. Over 72 genes have been identified to cause HSP and named by the order of discovery (SPG1-SPG72). HSP can be inherited in autosomal dominant, autosomal recessive or X-linked forms\[[@B2]\].

Among autosomal dominant HSP (AD-HSP) patients, spastic paraplegia 4 (*SPG4/SPAST*) is the most common pathogenic gene while the second most common one is atlastin-1 (*ATL1*)\[[@B3],[@B4]\]. The patients presenting with walking disturbances sometimes initially visit orthopaedic outpatient clinic for treatment. It is crucial to distinguish HSP from other orthopaedic diseases. Drugs, stretching and physiotherapy can reduce spasticity of HSP patients. In some severe HSP cases, orthopaedic surgery is also needed for improving contracture in the lower limbs\[[@B5]\]. Here we reported a novel *ATL1* Q251R mutation in a Chinese family with spastic paraplegia 3A (SPG3A), with a novel phenotype of hearing loss.

CASE PRESENTATION
=================

Chief complaints
----------------

A 9-year-old male student was admitted to our hospital orthopaedic outpatient clinic because of progressive spastic paraplegia accompanied by right hearing loss and mental retardation for five years.

History of present illness
--------------------------

Five years ago, the patient began to have difficulty in walking and climbing stairs progressively accompanied by right hearing loss and mental retardation.

History of past illness
-----------------------

His medical history was not remarkable.

Personal and family history
---------------------------

His family history was positive for spastic paraplegia (Figure [1](#F1){ref-type="fig"}). His grandfather (subject I:1 Figure [1](#F1){ref-type="fig"}) developed unsteady walking at 3 years old, while his mother presented the same symptoms (subject II:2 Figure [1](#F1){ref-type="fig"}) at 8 years old. His mother had no other symptoms, while his grandfather had mental retardation (Table [1](#T1){ref-type="table"}).

###### 

Clinical characteristics of the patient and affected family members

  **Characteristics**      **I:1**                                                 **II:2**                                                **III:1**
  ------------------------ ------------------------------------------------------- ------------------------------------------------------- -------------------------------------------------------------
  Gender                   Male                                                    Female                                                  Male
  Age at onset (yr)        3                                                       8                                                       4
  Past history             Lumbar disc herniation                                  None                                                    None
  Clinical presentations   Walking disturbance, mental retardation                 Walking disturbance                                     Walking disturbance, mental retardation, right hearing loss
  Physical examination                                                                                                                     
  Muscle strength          Normal                                                  Normal                                                  Lower limbs: grade 5-
  Muscle tension           Lower limbs: increase                                   Lower limbs: increase                                   Lower limbs: increase
  Sensory                  Normal                                                  Normal                                                  Normal
  Tendon reflex            Bilateral knee reflex[1](#T1FN1){ref-type="table-fn"}   Bilateral knee reflex[1](#T1FN1){ref-type="table-fn"}   Bilateral knee reflex[2](#T1FN2){ref-type="table-fn"}
  Babinski signs           Positive                                                Positive                                                Positive
  Gait                     Scissors gait                                           Scissors gait                                           Scissors gait
  Auxiliary examination                                                                                                                    
  MRI                      Normal                                                  Normal                                                  Mild atrophy of the spinal cord
  EMG/NCS                  NA                                                      Normal                                                  Right tibial nerve's F wave: Wide
  BAEP                     NA                                                      NA                                                      Right side hearing was impaired

Active;

Hyperreflexia. MRI: Magnetic resonance imaging; EMG: Electromyography; NCS: Nerve conduction study; BAEP: Brainstem auditory evoked potential; NA: Not available.

![The pedigree of the SPG3A family. The patient is indicated with arrow (III:1) and the affected families are indicated by solid boxes (I:1 and II:2).](WJCC-7-1358-g001){#F1}

Physical examination upon admission
-----------------------------------

Vital signs were in the normal ranges: Body temperature, 37.0 °C, respiratory rate, 21 breaths/min, pulse rate, 92 bpm and blood pressure, 98/60 mmHg. Neurological examinations revealed hypermyotonia in his lower limbs, hyperreflexia in knee reflex, and bilateral positive Babinski signs. He had scissors gait when walking. His lower limbs' muscle strengths were grade 5-/5.

Laboratory examinations
-----------------------

The results of blood routine test, urine routine test, stool routine test, liver function test, renal function test, serum creatase, serum electrolyte, plasma ammonia, blood glucose, ceruloplasmin test and vitamin test were all within normal ranges. The serum lactic acid level was significantly raised to 4.36 mmol/L (normal range: 1.42-1.90 mmol/L). The gene panel included 72 known pathogenic genes associated with spastic paraplegia (Supplement Table 1). Genetic testing revealed that the proband carried an *ATL1* c.752A\>G p.Gln251Arg (p.Q251R) mutation, and Sanger sequencing confirmed the existence of family co-segregation (Figure [2](#F2){ref-type="fig"}).

![DNA sequencing identified a novel *ATL1* c.752A\>G, p.Q251R mutation (top: sequence of the patients; bottom: sequence of healthy individuals).](WJCC-7-1358-g002){#F2}

Imaging examinations
--------------------

Magnetic resonance imaging (MRI) of the proband showed mild atrophy of the spinal cord (Figure [3](#F3){ref-type="fig"}), while the MRI results of his grandfather and mother were normal.

![Magnetic resonance imaging showed the mild atrophy the spinal cord. A: T1 sagittal view B: T2 sagittal view.](WJCC-7-1358-g003){#F3}

FINAL DIAGNOSIS
===============

A diagnosis of autosomal-dominant SPG3A was made based on previously published criteria\[[@B6]\].

TREATMENT
=========

Mecobalamine 0.5 mg three times a day, coenzyme Q10 400 mg twice a day and baclofen 5 mg three times a day were administrated to the patient.

OUTCOME AND FOLLOW-UP
=====================

No adverse effects were observed. The patient's symptoms deteriorated gradually in a follow-up visit after two months.

DISCUSSION
==========

To date, 68 *ATL1* pathogenic mutation types have been identified, most of which are missense mutations, followed by small insertions, small deletions and whole exon deletions. The mutation types were located in exon 12 (*n* = 29, 42.65%), exon 4 (*n* = 12, 17.65%), exon 8 (*n* = 8, 11.77%), exon 10 (*n* = 6, 8.82%), exon 7 (*n* = 4, 5.88%), exon 5 (*n* = 2, 2.94%), exon 11 (*n* = 2, 2.94%), exon 3 (*n* = 1, 1.47%), exon 6 (*n* = 1, 1.47%), exon 9 (*n* = 1, 1.47%), exon 13 (*n* = 1, 1.47%), and intron 1 (*n* = 1, 1.47%). The most common mutation genetic model is autosomal dominant (AD) inheritance (*n* = 57, 83.82%) while the sporadic is the second most common one (*n* = 7, 10.30%), and autosomal recessive (AR) inheritance is rare (*n* = 2, 2.94%) while two mutations' types are not available (*n* = 2, 2.94%) (Table [2](#T2){ref-type="table"})\[[@B4],[@B7]-[@B12]\]. Most *ATL1* mutation carriers develop pure HSP\[[@B4],[@B13],[@B14]\], while a few of them present with complicated phenotypes, such as seizure, optic atrophy, mental retardation and ataxia\[[@B15]\]. In China, the most common phenotype of *ATL1* mutation carriers is pure HSP while only one complicated phenotype was observed, namely muscular atrophy\[[@B16]-[@B21]\].

###### 

*ATL1* pathogenic mutations in hereditary spastic paraplegia

  **Exon**   **Nucleotide changes**   **Amino acid changes**   **Genetic model**
  ---------- ------------------------ ------------------------ -------------------
  3          G353A                    R118Q                    AR
  4          T452C                    F151S                    AD
  4          G458C                    S153T                    AD
  4          C460G                    Q154E                    AD
  4          C467T                    T156I                    AD
  4          T470G                    L157W                    AD
  4          T470C                    L157S                    AD
  4          G473C                    R158T                    AD
  4          G481C                    A161P                    AD
  4          A484C                    T162P                    AD
  4          T488C                    V163A                    AD
  4          G493A                    A165T                    AD
  5          C565G                    H189D                    AD
  5          A572G                    Q191R                    AD
  6          A587G                    Y196C                    AD
  7          C649T                    R217\*                   AR
  7          G650A                    R217Q                    AD
  7          C715T                    R239C                    AD
  7          G716T                    R239L                    AD
  8          A740C                    H247P                    AD
  8          T749C                    L250P                    AD
  8          C751A                    Q251K                    AD
  8          G757A                    V253I                    AD
  8          A773G                    H258R                    AD
  8          C777A                    S259Y                    AD
  8          C776T                    S259Y                    AD
  8          T776G                    S259F                    AD
  9          T944G                    I315S                    AD
  10         C1006T                   Y336H                    AD
  10         C1025A                   P342Q                    AD
  10         C1030T                   P344S                    S
  10         T1036G                   S346A                    AD
  10         T1040C                   M347T                    AD
  10         G1048T                   A350S                    AD
  11         A1064T                   N355I                    S
  11         C1065A                   N355K                    S
  12         T1123C                   C375R                    AD
  12         C1193A                   S398Y                    AD
  12         C1193T                   S398F                    S
  12         T1202C                   L401P                    S
  12         A1220G                   K407R                    AD
  12         A1222G                   M408V                    AD
  12         T1223C                   M408T                    AD
  12         A1222G                   M408T                    AD
  12         G1226A                   G409D                    S
  12         G1228A                   G410R                    AD
  12         A1237C                   F413V                    AD
  12         T1239C                   F413L                    AD
  12         C1242G                   S414R                    AD
  12         C1243T                   R415W                    AD
  12         A1244G                   R415Q                    AD
  12         C1246T                   R416C                    AD
  12         G1247A                   R416H                    AD
  12         T1308A                   N436K                    S
  12         A1319C                   N440T                    AD
  12         A1376G                   Y459C                    AD
  12         G1406C                   G469A                    AD
  12         G1445T                   G482V                    AD
  12         C1483T                   R495W                    AD
  13         G1556A                   S519N                    AD
  12         1306-1308delAAT          N436del                  AD
  4          Exon 4 del               140-174del               NA
  Intron 1   c.35-3C\>T               G13fsX16                 AD
  12         1462_1463insTG           T490Afs                  NA
  12         1466-1467insTG           T490fsX508               AD
  12         1474insG                 A492fsX522               AD
  12         1504-1505insG            E502fsX522               AD
  12         1520insA                 I507fsX522               AD

AR: Autosomal recessive; AD: Autosomal dominant; S: Sporadic; NA: Not available.

The impairments of the upper motor system can lead to spastic paraplegia, including cerebral palsy, brain injury, spinal cord infection, spinal cord tumor, and spinal cord injury\[[@B22]-[@B26]\]. Among them, the most common cause of spastic paraplegia in children is cerebral palsy, which can mimic HSP\[[@B27]\]. Consequently, it is important to identify HSP in orthopedic patients presenting with spastic paraplegia. Lumbosacral dorsal rhizotomy, botulinum toxin, and physiotherapy are effective ways to treat spasticity in children\[[@B28],[@B29]\].

In the present study, we detected a novel *ATL1* Q251R mutation, which is located in exon 8. *ATL1* Q251R was considered as a novel mutation, as it is absent in the Human Gene Mutation Database (HGMD) (<http://www.hgmd.cf.ac.uk/ac/index.php>) and clinvar database ([www.ncbi.nlm.nih.gov/clinvar/](www.ncbi.nlm.nih.gov/clinvar/)). Besides, no previous case has been reported with *ATL1* Q251R by searching it in PubMed and Web of Science. Protein Variation Effect Analyzer (PROVEN), Mutation Taster and Mutation Assessor were utilized to predict the pathogenicity of *ATL1* Q251R, and the results were described as deleterious, disease-causing and medium credible pathogenic, respectively. The amino-acid substitution replaced a neutrally charged glutamine for a positively charged arginine. Besides, *ATL1* Q251K was also reported to be a disease-causing mutation in HSP\[[@B30]\]. Consequently, the above evidence suggests that *ATL1* Q251R is likely to be a pathogenic mutation of HSP. Further functional studies are warranted to confirm its pathogenicity.

*ATL1* was firstly identified and reported to be pathogenic in five HSP kindreds\[[@B31]\]. It encodes for atlastin-1 (ATL1) protein that belongs to the dynamin family of guanosine triphosphatases (GTPases). ATL1 protein has a vital role in homotypic endoplasmic reticulum fusion, which is likely to be the underlying mechanism in the pathogenesis of HSP\[[@B32]\].

In our SPG3A family, we found that the proband and affected family members exhibit different clinical manifestations despite having the same mutation. The proband developed progressive walking disturbance accompanied by hearing loss and mental retardation, while his mother exhibited pure HSP symptoms and his grandfather also had mental retardation but no hearing dysfunction. This clearly indicates that SPG3A is clinically heterogeneous. The intra-family variable penetrance may result from environmental modifiers as well as regulatory variants\[[@B33]\]. Furthermore, sex and mutation types are of great importance in modifying the penetrance in HSP\[[@B34]\]. In our SPG3A family, regulatory variants, gender differences and environmental factors may be the underlying contributors to different phenotypes.

Our group previously analyzed the clinical spectrum of HSP in China and found that most of cases were pure one, whereas a few showed complicated phenotypes like atrophy in extremities\[[@B35]\]. Only a few HSP patients develop deafness or hearing loss in the course of the disease, however, none of SPG3A patients with deafness or hearing loss has been reported\[[@B36]\]. The patient we presented here developed progressive walking disturbance accompanied by hearing loss. Therefore, we also presented a novel clinical phenotype in SPG3A, hearing loss.

Furthermore, both neurological defects and orthopaedic diseases can result in movement abnormalities\[[@B5]\]. In fact, orthopaedic surgeons are usually the first doctors who are visited by patients with walking disturbances or gait abnormalities, including HSP patients presenting with progressive spasmodic paraplegia. For example, a Caucasian girl was misdiagnosed with cerebral palsy and a final correct diagnosis of SPG3A was made by genetic testing\[[@B12]\]. Consequently, careful medical history inquiry and physical examination are extremely important for diagnosis. In some cases, no definite diagnosis can be established by an orthopaedic surgeon alone. The evaluation of a neurologist or multidisciplinary team including a neurologist is essential for correct diagnosis. Besides, the treatments of HSP also involve appropriate orthopaedic therapies, such as surgery in severe HSP patients\[[@B37]\].

CONCLUSION
==========

In conclusion, we reported a novel *ATL1* Q251R mutation which is likely to be pathogenic and a clinically novel phenotype of hearing loss in a Chinese SPG3A family, which expands the clinical and genetic spectrum of *ATL1* mutations. SPG3A was clinically heterogeneous even with the same pathogenic mutation. In addition, this report emphasizes the importance of distinguishing HSP patients from other patients in orthopaedic outpatient clinic.
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